Stockscreener 앱 받기
33.15
3.92%
1.25
전일 마감가:
$31.90
열려 있는:
$31.84
하루 거래량:
242.88K
Relative Volume:
0.62
시가총액:
$967.60M
수익:
$219.79M
순이익/손실:
$-57.47M
주가수익비율:
-15.42
EPS:
-2.15
순현금흐름:
$-19.25M
1주 성능:
+1.22%
1개월 성능:
-16.37%
6개월 성능:
+70.79%
1년 성능:
+20.07%
1일 변동 폭
$31.84
$33.66
1주일 범위
$31.38
$33.66
52주 변동 폭
$14.59
$44.28
Castle Biosciences Inc Stock (CSTL) Company Profile
명칭
Castle Biosciences Inc
전화
866-788-9007
주소
505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX
Compare CSTL vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CSTL
Castle Biosciences Inc
|
33.15 | 931.12M | 219.79M | -57.47M | -19.25M | -2.15 |
|
TMO
Thermo Fisher Scientific Inc
|
504.82 | 191.54B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
212.58 | 151.94B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
629.35 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
125.81 | 35.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
323.37 | 31.37B | 3.17B | 642.63M | 539.81M | 10.77 |
Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-01-07 | 개시 | Stephens | Overweight |
| 2021-04-30 | 개시 | Lake Street | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2019-12-27 | 재확인 | Canaccord Genuity | Buy |
| 2019-08-19 | 개시 | BTIG Research | Buy |
| 2019-08-19 | 개시 | Canaccord Genuity | Buy |
| 2019-08-19 | 개시 | Robert W. Baird | Outperform |
| 2019-08-19 | 개시 | SVB Leerink | Outperform |
모두보기
Castle Biosciences Inc 주식(CSTL)의 최신 뉴스
Analysis Recap: Whats next for Castle Biosciences Inc stockJuly 2025 Sentiment & Technical Buy Zone Confirmation - baoquankhu1.vn
Earnings Recap: Will Castle Biosciences Inc stock go up in YEAR2025 Big Picture & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Castle Biosciences stock jumps after FDA grants Breakthrough Device status to melanoma test - MSN
EV Market: Can Castle Biosciences Inc deliver alpha2025 Stock Rankings & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Aug Weekly: Can Castle Biosciences Inc. maintain its current growth rateEarnings Overview Report & Long-Term Investment Growth Plans - baoquankhu1.vn
Castle Biosciences (CSTL) Loses 16.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Finviz
Castle Biosciences, Inc. $CSTL Shares Sold by Allianz Asset Management GmbH - MarketBeat
Castle Biosciences, Inc. (CSTL) Stock Analysis: Exploring a 49.91% Upside Potential for Investors - DirectorsTalk Interviews
Insider Selling: Castle Biosciences (NASDAQ:CSTL) Insider Sells 3,200 Shares of Stock - MarketBeat
Derek Maetzold Sells 817 Shares of Castle Biosciences (NASDAQ:CSTL) Stock - MarketBeat
What Catalysts Are Rewriting The Castle Biosciences (CSTL) Story For Wall Street Analysts - Yahoo Finance
Neurocrine Biosciences to Report Q4 Earnings: What's in the Cards? - Finviz
Castle Biosciences to Release Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call on Thursday, Feb. 26, 2026 - The Manila Times
Castle Biosciences to Release Fourth Quarter and Full-Year - GlobeNewswire
Castle Biosciences Enters Oversold Territory (CSTL) - Nasdaq
Castle Biosciences (NASDAQ:CSTL) Upgraded to "Strong-Buy" at Zacks Research - MarketBeat
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Retail Trends: Should you avoid Castle Biosciences Inc stock right nowQuarterly Trade Report & Community Verified Watchlist Alerts - baoquankhu1.vn
The Analyst Verdict: Castle Biosciences In The Eyes Of 7 Experts - Benzinga
Are you looking for a top momentum pick? Why Castle Biosciences, Inc. (CSTL) is a great choice - MSN
Aug Outlook: How sensitive is Castle Biosciences Inc to inflationMarket Risk Report & Entry Point Strategy Guides - baoquankhu1.vn
AIGH Capital Management LLC Acquires New Position in Castle Biosciences, Inc. $CSTL - Defense World
Are You Looking for a Top Momentum Pick? Why Castle Biosciences, Inc. (CSTL) is a Great Choice - Yahoo Finance
Castle Biosciences, Inc. (CSTL) Stock Analysis: A Healthcare Innovator with Strong Buy Ratings and 9.13% Upside Potential - DirectorsTalk Interviews
Castle Biosciences stock hits 52-week high at $42.25 By Investing.com - Investing.com Nigeria
Castle Biosciences (NASDAQ:CSTL) Insider Derek Maetzold Sells 4,017 Shares - MarketBeat
Castle Biosciences (NASDAQ:CSTL) Hits New 12-Month HighWhat's Next? - MarketBeat
Castle Biosciences stock hits 52-week high at $42.25 - Investing.com
26,996 Shares in Castle Biosciences, Inc. $CSTL Acquired by Campbell & CO Investment Adviser LLC - MarketBeat
Risk Hedge: What are the future prospects of Castle Biosciences IncCPI Data & Daily Volume Surge Signals - baoquankhu1.vn
Insider Buy: What are the future prospects of Castle Biosciences IncQuarterly Market Review & Free Community Supported Trade Ideas - baoquankhu1.vn
Zacks.com Spotlights Perimeter Solutions, Interface, Castle Biosciences, and Great Lakes Dredge & Dock - Intellectia AI
Market Rankings: How sensitive is Castle Biosciences Inc to inflationJuly 2025 Weekly Recap & Daily Momentum Trading Reports - baoquankhu1.vn
Dividend Watch: How sensitive is Castle Biosciences Inc. to inflationAnalyst Downgrade & Weekly Return Optimization Plans - baoquankhu1.vn
Market Trends: Will Castle Biosciences Inc stock deliver better than expected guidance - Bộ Nội Vụ
Castle Biosciences (CSTL) Gets a Buy from Lake Street - The Globe and Mail
Castle Biosciences (CSTL) Sees PT Raised by Lake Street: Analyst Insights | CSTL Stock News - GuruFocus
Castle Biosciences (CSTL) Valuation After Upgraded 2025 Guidance And Strong Core Test Volume Growth - Yahoo Finance
The Bull Case For Castle Biosciences (CSTL) Could Change Following Surging Test Volumes And Raised 2025 Outlook - Yahoo Finance
Castle Biosciences (CSTL) Expects 2025 Revenue to Surpass $340 M - GuruFocus
Castle Biosciences Expects 2025 Revenue to Exceed $340 Million - Intellectia AI
Castle Biosciences 2025 total revenue expected to exceed $340 million - marketscreener.com
Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results - The Manila Times
Castle Biosciences 2025 Total Revenue Expected To Exceed $340 Million - TradingView — Track All Markets
San Gabriel Valley Tribune - FinancialContent
Castle Biosciences to buy Previse - MSN
Castle Biosciences, Inc. (CSTL) Stock Analysis: Riding the Wave of Healthcare Innovation with 9.68% Upside Potential - DirectorsTalk Interviews
Can Castle Biosciences Inc. stock continue upward trendWeekly Profit Analysis & Daily Profit Maximizing Tips - Улправда
What risks investors should watch in Castle Biosciences Inc. stock2025 Support & Resistance & AI Powered Buy/Sell Recommendations - Улправда
How resilient is Castle Biosciences Inc. stock in market downturnsShare Buyback & Consistent Return Investment Signals - ulpravda.ru
Why Castle Biosciences Inc. stock is considered a top pickBull Run & Weekly High Potential Alerts - ulpravda.ru
Castle Biosciences Inc (CSTL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
1.13%
자본화:
|
볼륨(24시간):